article · Frontiers in Chemistry
The present study details the design, synthesis, and bio-evaluation of indoles 3–16 as dual inhibitors of aromatase and inducible nitric oxide synthase (iNOS)with antiproliferative activity. The study evaluates the antiproliferative efficacy of 3–16 against various cancer cell lines, highlighting hybrids 12 and 16 for their exceptional activity with GI 50 values of 25 nM and 28 nM, respectively. The inhibitory effects of the most active hybrids 5, 7, 12 , and 16 , on both aromatase and iNOS were evaluated. Compounds 12 and 16 were investigated for their apoptotic potential activity, and the results showed that the studied compounds enhance apoptosis by activating caspase-3, 8, and Bax and down-regulating the anti-apoptotic Bcl-2. Molecular docking studies are intricately discussed to confirm most active hybrids’ 12- and 16 -binding interactions with the aromatase active site. Additionally, our novel study discussed the ADME characteristics of derivatives 8–16 , highlighting their potential as therapeutic agents with reduced toxicity.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3389/fchem.2024.1432920
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.